TVARDI THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Deferred Revenue of -$1.45 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-15
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2015-09-30 was -$89.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2015-06-30 was -$874.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2015-03-31 was -$489.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$1.45M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2014 was -$2.02M, a 158.22% decline from fiscal 2013.
- TVARDI THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2013 was $3.48M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$89.00K derived: sum of 2 quarters · filed 2018-03-15 | -$963.00K derived: sum of 3 quarters · filed 2018-03-15 | -$1.45M 10-K · filed 2018-03-15 |
| 2015-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$963.00K derived: sum of 2 quarters · filed 2016-11-04 | -$1.45M 10-Q · filed 2016-11-04 | -$1.94M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | -$874.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.36M 10-Q · filed 2016-08-04 | -$1.85M derived: sum of 3 quarters · filed 2017-03-10 | -$2.98M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | -$489.00K 10-Q · filed 2016-05-05 | -$981.00K derived: sum of 2 quarters · filed 2017-03-10 | -$2.11M derived: sum of 3 quarters · filed 2017-03-10 | -$2.45M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | -$492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$1.62M derived: sum of 2 quarters · filed 2017-03-10 | -$1.97M derived: sum of 3 quarters · filed 2017-03-10 | -$2.02M 10-K · filed 2017-03-10 |
| 2014-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.47M derived: sum of 2 quarters · filed 2015-11-09 | -$1.53M 10-Q · filed 2015-11-09 | -$2.49M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$406.00K 10-Q · filed 2015-08-10 | -$1.36M derived: sum of 3 quarters · filed 2016-03-11 | -$2.33M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$58.00K 10-Q · filed 2015-05-12 | -$1.02M derived: sum of 2 quarters · filed 2016-03-11 | -$1.98M derived: sum of 3 quarters · filed 2016-03-11 | |
| 2013-12-31 | -$959.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$1.92M derived: sum of 2 quarters · filed 2016-03-11 | $3.48M 10-K · filed 2016-03-11 | |
| 2013-09-30 | -$960.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $4.43M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $5.39M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |